Grant opportunity · PAR-25-075
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH3 Clinical Trials Not Allowed)
Who can apply (as listed)
- City or township governments
- State governments
- Others (see the opportunity text)
- Public and state-controlled institutions of higher education
- Public housing authorities / Indian housing authorities
- Native American tribal organizations (other than federally recognized governments)
- Small businesses
- Independent school districts
- County governments
- Special district governments
- Nonprofits with 501(c)(3) status (other than institutions of higher education)
- Native American tribal governments (federally recognized)
- For-profit organizations (other than small businesses)
- Private institutions of higher education
- Nonprofits without 501(c)(3) status (other than institutions of higher education)
Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) intends to accelerate the adoption and validation of molecular/cellular/imaging markers (referred to as "markers" or "biomarkers") and assays for cancer detection, diagnosis, prognosis, monitoring, and prediction of response or resistance to treatment, as well as markers for cancer prevention and control. This NOFO will also support the validation of pharmacodynamic markers and markers of toxicity. Applicants to this NOFO must have an assay(s) whose performance has been analytically validated in specimens similar to those for the intended clinical use of the marker(s) and assay(s). As chemotherapies and/or radiation therapies are increasingly combined with immunotherapies to enhance the durability of anti-cancer responses, assays for measuring multiple markers, including immune markers, can be developed and validated simultaneously. The UH3 mechanism will support the clinical validation of establish…
Excerpt as published. The full synopsis, required forms, and any amendments are on the official listing.
GrantSet indexes public records and is not the official application channel. Responses and applications go through Grants.gov only — the official notice there controls if anything shown here differs.